Pharma Mar S.A. | Mutual Funds
Mutual Funds that own Pharma Mar S.A.
Government Pension Fund - Global (The)
3,926,609
1.76%
407,935
0%
12/31/2017
Vanguard Total International Stock Index Fund
2,148,242
0.97%
0
0%
07/31/2018
iShares MSCI EAFE Small Cap ETF
1,260,118
0.56%
0
0.02%
09/06/2018
JPMorgan Funds - Global Healthcare Fund
1,128,176
0.51%
-533,983
0.07%
05/31/2018
DFA Continental Small Company Series
1,078,930
0.49%
0
0.03%
01/31/2018
Santander Small Caps España, FI
1,004,069
0.45%
-1,024,247
0.19%
12/31/2017
Vanguard Developed Markets Index Fund
934,420
0.42%
0
0%
07/31/2018
iShares Core MSCI EAFE ETF
804,018
0.36%
0
0%
09/06/2018
Bankia Small & Mid Caps España, FI
707,851
0.32%
-270,204
1.03%
12/31/2017
Stichting Pensioenfonds ABP (Global Equity Portfolio)
606,796
0.27%
-1,106
0%
03/31/2018
| Address |
Avenida de los Reyes, 1
Colmenar Viejo Madrid 28770
Spain
|
|
Employees
|
- |
| Website |
http://www.pharmamar.es |
| Updated |
07/08/2019 |
| Pharma Mar SA is a biopharmaceutical holding company, which engages in discovery and development of innovative marine-derived anticancer drugs. It operates through the following segments: Oncology, Diagnostics, RNAi, and Consumer Chemicals. The Oncology segment encompasses the Group undertakings whose object is to research, develop and market anti-tumour drugs. |
